Gland Celsus Bio Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.66 Cr
- Company Age 17 Year,
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Ebitda
- Net Worth -8.00%
- Total Assets 10.19%
About Gland Celsus Bio Chemicals
Gland Celsus Bio Chemicals Private Limited (GCBCPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 February 2008 and has a history of 17 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Penmetsa Ravindranath, Kalidindi Lakshmi, and Gopi Devarakonda serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74110TG2008PTC057789
- Company No.
057789
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Gland Celsus Bio Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Penmetsa Ravindranath  | Director | 09-Mar-2022 | Current |
Kalidindi Lakshmi  | Director | 09-Mar-2022 | Current |
| Gopi Devarakonda | Director | 14-Mar-2022 | Current |
Financial Performance of Gland Celsus Bio Chemicals.
Gland Celsus Bio Chemicals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gland Celsus Bio Chemicals?
In 2018, Gland Celsus Bio Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ilabs Info Technology Center (Gurgaon) Private LimitedKalidindi Lakshmi is a mutual person
Valar Capital Advisory LlpPenmetsa Ravindranath and Kalidindi Lakshmi are mutual person
Ksk Energy Ventures LimitedPenmetsa Ravindranath, Kalidindi Lakshmi and 1 more are mutual person
Dhananjaya Properties LlpPenmetsa Ravindranath and Kalidindi Lakshmi are mutual person
- Markanday Properties Llp
Penmetsa Ravindranath and Kalidindi Lakshmi are mutual person
- Sasikala Properties Llp
Penmetsa Ravindranath and Kalidindi Lakshmi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gland Celsus Bio Chemicals?
Unlock and access historical data on people associated with Gland Celsus Bio Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gland Celsus Bio Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gland Celsus Bio Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
